• Made-In-Singapore Cancer Drug Advances To Clinical Trials

    Asian Scientist Magazine | ETC-159, a Wnt-targeting anti-cancer drug indicated for colorectal, ovarian and pancreatic cancers, has entered a Phase I clincial trial.

    Jul 20, 2015

  • HIPAA’s Use as Code of Silence Often Misinterprets the Law

    New York Times | The protection of a patient's health information does not prohibit health care providers from sharing information with family, friends and caregivers.

    Jul 17, 2015

  • FDA Grants Blueprint Go-Ahead for Kinase Inhibitor Trials

    Xconomy | Blueprint Medicines got the green light from the Food and Drug Administration to begin clinical trials on its two lead drug candidates for cancer, about two months after its IPO.

    Jul 13, 2015

  • Concerns and Skepticism Around 21st Century Cures Act

    Washington Post | While some measures in the bipartisan 21st Century Cures Act, like increased NIH funding, have attracted widespread praise, other measures threaten to weaken the safety and efficacy evidence needed for drugs to pass muster with the FDA.

    Jul 10, 2015

  • After Celgene Deal Juno Revs Armored CAR For Ovarian Cancer Trial

    Xconomy | Juno Therapeutics has built remarkable momentum and is about to launch the first trial in humans of engineered T cells.

    Jul 10, 2015

  • Hospital ICUs Mine Big Data in Push for Better Outcomes

    WSJ | Leading hospitals such as Beth Israel Deaconess Medical Center in Boston and Johns Hopkins Medicine in Baltimore look for clues in the wealth of information from past cases.

    Jul 9, 2015

  • Do No Harm

    Vox | An investigation into heart line catheter infections reveals the harm analysis strategies that let hospitals prevent deadly medical errors.

    Jul 9, 2015

  • Consulting Merger Creates Certara Strategic Consulting

    Clinical Informatics News | Certara has merged its consulting group, Pharsight Consulting Services (PCS), with Quantitative Solutions, a global pharmacometrics consulting company headquartered in Menlo Park, Calif. forming Certara Strategic Consulting. Jaap Mandema, former CEO of Quantitative Soutions, will serve as the new head of Certara Strategic Consulting. Financial details were not disclosed.

    Jul 8, 2015

  • UCSD Asks Court to Restore Custody and Control of Alzheimer’s Data

    Xconomy | In the recent donnybrook between UC San Diego and the University of Southern California, the 24-year old Alzheimer's Disease Cooperative Study is what's at stake.

    Jul 8, 2015

  • World Health Organization Scolds Indian Company for Clinical Trial Violations

    WSJ | Yet another contract research organization in India is being scolded for its handling of clinical trial records.

    Jul 7, 2015

  • Social Media Insights Company Launches App for Social Listening

    Clinical Informatics News | Treato, a social media insights company that describes itself as the world’s largest “patient voice” source, has announced it will apply its big data infrastructure and technology to social media networks, giving patients a platform to discuss treatments and allowing the medical and business communities to gauge real-time patient attitudes, view social trends, and gain insights into their—and their competitors’—advertisements and products.

    Jul 6, 2015

  • Sequenced at Birth

    MIT Technology Review | BabySeq, a study examining the health outcomes of sequencing newborns' genomes, has enrolled its first four subjects at Boston hospitals.

    Jul 2, 2015

  • June Clinical News and Product Briefs

    Clinical Informatics News | Clinical news and product briefs from around the industry, including a host of new trial management solutions unveiled at DIA 2015.

    Jul 1, 2015

  • IMS Health to Acquire ViS Research

    Clinical Informatics News Brief | IMS Health tweeted out news of its acquisition of ViS Research last week during the DIA annual meeting. 

    Jun 24, 2015

  • A Bill Would Prevent Drug Makers From Frustrating Generic Rivals

    WSJ | A pair of lawmakers has reintroduced a bill designed to end a practice that generic drug makers complain is used by brand-name counterparts to thwart competition.

    Jun 23, 2015

  • New Board Chairman Jeffrey Kasher Bringing Speed to DrugDev

    Clinical Informatics News | DrugDev, a provider of cloud-based solutions for clinical trials, has tapped Jeffrey Kasher, Ph.D., as Chairman of the Advisory Board.  

    Jun 22, 2015